D
Dana P. Goldman
Researcher at University of Southern California
Publications - 381
Citations - 16877
Dana P. Goldman is an academic researcher from University of Southern California. The author has contributed to research in topics: Health care & Population. The author has an hindex of 62, co-authored 377 publications receiving 15247 citations. Previous affiliations of Dana P. Goldman include George Washington University & Dana Corporation.
Papers
More filters
Journal ArticleDOI
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
Joy H Lewis,Meredith L. Kilgore,Dana P. Goldman,Edward L. Trimble,Richard Kaplan,Michael Montello,Michael G. Housman,Jose Escarce +7 more
TL;DR: The elderly are underrepresented in cancer clinical trials relative to their disease burden, and older patients are more likely to have medical histories that make them ineligible for clinical trials because of protocol exclusions.
Journal ArticleDOI
Prescription drug cost sharing: associations with medication and medical utilization and spending and health.
TL;DR: Pharmacy benefit design represents an important public health tool for improving patient treatment and adherence and increased cost sharing is highly correlated with reductions in pharmacy use, but the long-term consequences of benefit changes on health are still uncertain.
Journal ArticleDOI
Variations in the Care of HIV-Infected Adults in the United States: Results From the HIV Cost and Services Utilization Study
Martin F. Shapiro,Sally C. Morton,Daniel F. McCaffrey,J W Senterfitt,John A. Fleishman,Judith F. Perlman,Leslie A. Athey,Joan Keesey,Dana P. Goldman,Sandra H. Berry,Samuel A. Bozzette,Samuel A. Bozzette +11 more
TL;DR: The authors in this article examined variations in the care received by a national sample representative of the adult US population infected with HIV and found that not all individuals infected with human immunodeficiency virus (HIV) receive adequate care.
Journal ArticleDOI
Differences in life expectancy due to race and educational differences are widening, and many may not catch up.
S. Jay Olshansky,Toni C. Antonucci,Lisa F. Berkman,Robert H. Binstock,Axel H. Boersch-Supan,John T. Cacioppo,Bruce A. Carnes,Laura L. Carstensen,Linda P. Fried,Dana P. Goldman,James S. Jackson,Martin Kohli,John Rother,Yuhui Zheng,John W. Rowe +14 more
TL;DR: Estimates of the impact of race and education on past and present life expectancy are updated, trends in disparities from 1990 through 2008 are examined, and observed disparities are placed in the context of a rapidly aging society that is emerging at a time of optimism about the next revolution in longevity.
Journal ArticleDOI
Pharmacy Benefits and the Use of Drugs by the Chronically Ill
Dana P. Goldman,Geoffrey F. Joyce,José J. Escarce,Jennifer E. Pace,Matthew D. Solomon,Marianne Laouri,Pamela B. Landsman,Steven M. Teutsch +7 more
TL;DR: The use of medications such as antihistamines and NSAIDs, which are taken intermittently to treat symptoms, was sensitive to co-payment changes, and other medications--antihypertensive, antiasthmatic, antidepressant, antihyperlipidemic, antiulcerant, and antidiabetic agents--also demonstrated significant price responsiveness.